The CHA2DS2-VASc Score as an Early Predictor of Graft Failure After Coronary Artery Bypass Surgery

被引:3
|
作者
Tasbulak, Omer [1 ]
Sahin, Anil [1 ]
机构
[1] Univ Hlth Sci, Mehmet Akif Ersoy Thorac & Cardiovasc Surg Traini, Cardiol, Istanbul, Turkey
关键词
graft; graft failure; graft patency; coronary artery bypass surgery; cha2ds2-vasc; IN-HOSPITAL MORTALITY; SAPHENOUS-VEIN; DISEASE; ATHEROSCLEROSIS; VALIDATION; BURDEN; STROKE;
D O I
10.7759/cureus.22833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective Graft patency is one of the major concerns after coronary artery bypass graft (CABG) surgery. The CHA(2)DS(2)-VASc [congestive heart failure, hypertension, age >= 75 years, diabetes mellitus (DM), stroke or transient ischemic attack (TIA), vascular disease, age 65 to 74 years, sex category] score is a tool that was developed to predict the risk of thrombotic events in patients with atrial fibrillation (AF). In this study, we evaluated the use of the CHA(2)DS(2)-VASc score as a simple tool for predicting graft failure (GF) among patients who underwent CABG surgery. Methods In this retrospective case-control study, a total of 280 patients were enrolled after applying the exclusion criteria. Angiograms were analyzed by using the QCA software system (Pie Medical Imaging, Maastricht, The Netherlands) for each patient. A graft was described as failed if it had 70% or more stenosis or was completely occluded. Patients were classified into two groups: group one included patients without GF (GF-N) and group two included patients with GF (GF-Y). Thereafter, the CHA(2)DS(2)-VASc risk score was calculated for each patient. Results In our cohort, 136 patients had GF (GF-Y group) and 144 patients did not have GF (GF-N group). GF-N and GF-Y patients had their angiography performed 100.31 +/- 8.04 and 103.49 +/- 8.41 months after CABG, respectively. GF-Y group had a significantly higher rate of DM, hypertension, and heart failure with reduced ejection fraction (HFrEF). GF-Y group had higher CHA(2)DS(2) (GF-N group: 1.47 +/- 0.91 vs. GF-Y group: 2.57 +/- 1.17, p=0.0001) and CHA(2)DS(2)-VASc score (GF-N group: 2.80 +/- 1.11 vs. GE-Y group: 4.15 +/- 1.25, p=0.0001). Analyses showed that only CHA(2)DS(2)-VASc was an independent predictor of GF while other parameters including DM, hypertension, HFrEF, creatinine, and CHADS(2) were not found to be independent predictors of GE. A CHA(2)DS(2)-VASc score of >3 predicted GF with a sensitivity of 65.44% and a specificity of 74.31%. Conclusions The CHA(2)DS(2)-VASc score might be used as a feasible and simple method to predict the risk of GF after CABG surgery.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Usefulness of the CHA2DS2-VASC Score to Predict Adverse Outcomes in Patients Having Percutaneous Coronary Intervention
    Orvin, Katia
    Bental, Tamir
    Assali, Abid
    Lev, Eli Israel
    Vaknin-Assa, Hana
    Kornowski, Ran
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (09) : 1433 - 1438
  • [32] Does CHA2DS2-VASc score predict mortality in chronic kidney disease?
    Goudis, Christos
    Daios, Stylianos
    Korantzopoulos, Panagiotis
    Liu, Tong
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (07) : 1737 - 1742
  • [33] Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score
    Kaplan, Rachel M.
    Koehler, Jodi
    Ziegler, Paul D.
    Sarkar, Shantanu
    Zweibel, Steven
    Passman, Rod S.
    CIRCULATION, 2019, 140 (20) : 1639 - 1646
  • [34] Use of the CHA2DS2-VASc Score to Predict Concurrent Critical Coronary Artery Stenosis in Patients with Severe Carotid Artery Disease
    Baran, O.
    Yilmaz, Y.
    Inci, S.
    Cetinkaya, Z.
    Kelesoglu, S.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2025, 28 (04) : 487 - 495
  • [35] The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention
    Parfrey, Shane
    Teh, Andrew W.
    Roberts, Louise
    Brennan, Angela
    Clark, David
    Duffy, Stephen J.
    Ajani, Andrew E.
    Reid, Christopher M.
    Freeman, Melanie
    CORONARY ARTERY DISEASE, 2021, 32 (04) : 288 - 294
  • [36] CHA2DS2-VASc is no longer enough
    Reiffel, James A.
    EUROPACE, 2022,
  • [37] CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation
    Saliba, Walid
    Rennert, Gad
    AMERICAN JOURNAL OF MEDICINE, 2014, 127 (01) : 45 - 52
  • [38] Comparison between CHADS2 and CHA2DS2-VASc score in a stroke cohort with atrial fibrillation
    Giralt-Steinhauer, E.
    Cuadrado-Godia, E.
    Ois, A.
    Jimenez-Conde, J.
    Rodriguez-Campello, A.
    Soriano, C.
    Roquer, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2013, 20 (04) : 623 - 628
  • [39] CHA2DS2-Vasc score and CHA2DS2-Vasc-HS score are poor predictors of in-stent restenosis among patients with coronary drug-eluting stents
    Zhao, Sheng Gang
    Xu, Jian Jiang
    Tao, Zhen Hao
    Jin, Lei
    Liu, Qin
    Zheng, Wen Yue
    Jiang, Li Qin
    Wang, Ning Fu
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (06) : 2533 - 2544
  • [40] CHA2DS2-VASc-HSF Score: A Novel and Simple Independent Predictor for Severe Coronary Artery Disease
    Al-Farabi, M. J.
    Semita, I. G. P. G.
    Shonafi, K. A.
    Jovie, B.
    Andrianto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F71 - F71